Escherichia coli

Overview

Escherichia coli is a Gram-negative, rod-shaped bacterium in the family Enterobacteriaceae and a common inhabitant of the intestinal tract of humans and other warm-blooded animals. Most strains are harmless commensals and are widely used as model organisms in microbiology, genetics, and biotechnology. Because of its rapid growth, well-characterized genetics, and ease of cultivation, E. coli is one of the most important bacterial chassis for recombinant protein expression, metabolic engineering, biosensor construction, and synthetic biology.

At the same time, certain lineages are clinically significant pathogens. Pathogenic E. coli can cause intestinal disease, urinary tract infection, neonatal sepsis, meningitis, and other extraintestinal infections. Its outer membrane lipopolysaccharide, metabolic flexibility, and capacity to acquire resistance determinants such as NDM-5 and other β-lactamase-associated mechanisms make it a major target in antimicrobial research. In recent biomedical studies, E. coli has therefore served both as a disease-causing organism and as an engineered platform for producing Amino Acids, nucleotides, glycosides, and other valuable compounds.

Focus of Latest Publications

Recent publications investigating Escherichia coli as a therapeutic target demonstrate substantial progress in developing alternative antimicrobial strategies, driven by mounting concerns over antibiotic resistance. A significant body of research evaluates plant extracts and essential oils—derived from guava leaf, Lamiaceae species (Thymus vulgaris, Rosmarinus officinalis), Ocimum basilicum, Sonneratia ovata, and citrus peel waste—as natural antimicrobial agents. These compounds typically demonstrate dose-dependent antibacterial activity against E. coli through mechanisms including bacterial membrane disruption and oxidative stress. Aqueous guava leaf extract showed minimum inhibitory concentration (MIC) values of 800 μg/mL, while essential oils from thyme effectively reduced E. coli biofilm at two-fold MIC with seven-log-phase reductions. Complementary investigations have focused on nanoparticle-based systems—including silver, zinc oxide, magnesium oxide, and selenium nanoparticles synthesized via green chemistry—which consistently demonstrate enhanced antimicrobial potency relative to free phytochemical compounds, with several achieving rapid bactericidal effects at substantially lower effective concentrations.

Advanced drug delivery platforms have emerged as a critical focus for managing biofilm-associated and multidrug-resistant E. coli infections. Hydrogel systems incorporating essential oils, botanical extracts, and functional nanoparticles have been extensively characterized for wound healing applications, many exploiting photothermal or photocatalytic mechanisms for synergistic antimicrobial effects. Microneedle-based transdermal delivery technologies—including core-shell formulations with chito-oligosaccharide shells and chondroitin sulfate cores, and MXene nanosheets conjugated with deferoxamine—have demonstrated significant advantages over topical application by enabling penetration to deep tissue infection sites. These systems achieved inhibition rates against E. coli reaching 98.8% in vitro, with in vivo validation in diabetic and burn wound infection models showing accelerated healing, enhanced collagen deposition, and reduced inflammatory markers compared to conventional antimicrobials and untreated controls.

Novel antimicrobial mechanisms circumventing classical antibiotic resistance pathways have been identified and characterized. Chemical proteomics and functional studies have revealed that certain natural product-derived compounds simultaneously target bacterial protein synthesis initiation (via InfA) and flagellar assembly (FliC), resulting in impaired motility and reduced host cell invasion. Photocatalytic and photothermal nanomaterials—including visible-light-driven carbon dot hydrogels, magnesene nanosheets that induce localized magnesium overload at the bacterial interface, and iron-based metal-organic frameworks engineered to preferentially generate superoxide and hydroxyl radicals—demonstrate broad-spectrum efficacy through oxidative mechanisms fundamentally distinct from conventional antibiotics. These approaches show particular promise against multidrug-resistant E. coli, where classical resistance mechanisms offer no protection.

Clinical applications and diagnostic innovations have expanded in parallel with therapeutic developments. Rare presentations such as E. coli meningoencephalitis in immunocompetent adults underscore its clinical significance across diverse infection contexts. Diagnostic advances include rapid molecular detection of resistance genes (blaOXA-1) combining thermal-optimized PCR with CRISPR-Cas12a systems, achieving results within 50 minutes, and multiplexed pathogen detection platforms utilizing DNAzyme-driven rolling-circle amplification coupled with machine-learning image analysis. Additionally, exosome-mediated antibiotic delivery has been developed to enhance intracellular drug penetration in neonatal sepsis, achieving superior eradication of multidrug-resistant E. coli in macrophage models while maintaining cellular viability substantially higher than free antibiotic formulations.

Key Publications

• NEWJul Antibacterial Activities of Guava (Psidium guajava) Leaf Aqueous Extract Against Staphylococcus aureus and Escherichia coli. (Mymensingh medical journal : MMJ, 2026, PMID 42375034): "This study evaluated the in vitro antibacterial activity of aqueous extracts of guava (Psidium guajava) leaves against two pathogenic bacteria: Gram positive Staphylococcus aureus and Gram negative Escherichia coli."
• NEWJun Chemical fingerprints of Lamiaceae essential oils: targeting biofilm viability, biomass, metabolic activity, and membrane integrity. (Biofouling, 2026, PMID 42332877): "T. vulgaris oil effectively removed E. coli and P. aeruginosa biofilms at 2×MIC (log reduction 7) but was less effective against S. aureus (log reduction 1.7) at 2×MIC."
• NEWJun Hyaluronate-coated novasomes as a nanoplatform for targeted delivery of Beta vulgaris subsp. cicla extract: formulation, characterization, and phytochemical profiling. (Scientific reports, 2026, PMID 42303711): "The biological activities were evaluated via DPPH radical scavenging and agar well assays against Staphylococcus aureus, Escherichia coli, and Candida albicans."
• NEWJun Biosynthesis of ecofriendly antibacterial nanoparticles with healing effects in a murine diabetic skin infection model. (Scientific reports, 2026, PMID 42297939): "...against four bacterial strains associated with diabetic foot ulcers, including Pseudomonas aeruginosa, Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA), and Streptococcus pyogenes."
• NEWJun Synthesis of phytochemical-enriched MgO nanoparticles using Sonneratia ovata leaf extract for photocatalytic activity and inactivation of bacteria. (Journal of environmental management, 2026, PMID 42289157): "The green synthesis of MgO NPs was found to be a promising antimicrobial agent against pathogens such as Escherichia coli and Staphylococcus aureus."
• NEWJun Photothermal-Responsive Multifunctional Hydrogels as Integrated Smart Carriers for Antibiotic Controlled Release and Infected Wound Therapy. (Langmuir : the ACS journal of surfaces and colloids, 2026, PMID 42257624): "In vitro experiments showed that this hydrogel has a significant antibacterial effect against high concentrations (107 CFU·mL-1) of Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)."
• Jun Multifunctional chitosan films enriched with artichoke stem extract and microbial lipids for active food packaging. (International journal of biological macromolecules, 2026, PMID 42235764): "indicating strong antimicrobial efficacy against Escherichia coli and Staphylococcus aureus."
• Jun Programmable core-shell microneedles with marine chondroitin sulfate core and chito-oligosaccharide shell disrupt the pathological microenvironment cycle for enhanced healing of infected burn wounds. (International journal of biological macromolecules, 2026, PMID 42235776): "Specifically, CC-MN achieved antibacterial inhibition rates of 94.0%, 98.8%, and 99.5% against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, respectively."
• Jun A high-amylose maize starch hydrogel mask for stabilized encapsulation of thyme essential oil with Higuchi-controlled release. (International journal of biological macromolecules, 2026, PMID 42219099): "The TEO-loaded hydrogel (2% TEO) showed potent, dose-dependent antibacterial activity against Staphylococcus aureus (inhibition zone = 22 mm) and Escherichia coli (20 mm), achieving >95% bacterial reduction."
• Jun A two-stage signal enhancement method integrating the Gaussian mixture model and adaptive rolling ball technique for ultrasensitive fluorescent immunochromatographic detection. (Analytical methods : advancing methods and applications, 2026, PMID 42200343): "In Escherichia coli detection, the detection limit improved from 103 to 102 CFU mL-1, with a Pearson correlation coefficient of 0.998 compared with the PCR gold standard."